More from Renaissance Capital

Omthera Pharmaceuticals files for a $75 million IPO

By Renaissance Capital,  March 11, 2013, 09:30:58 AM EDT

Omthera Pharmaceuticals, which is developing therapies for abnormalities in blood lipids, filed on Monday with the SEC to raise up to $75 million in an initial public offering. The Princeton, NJ-based company, which was founded in 2008, currently does not produce any revenue from its drug candidates. It plans to list on the NASDAQ under the symbol OMTH. BofA Merrill Lynch, Barclays and Leerink Swann are the joint bookrunners on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks:



Latest News Video

How to Pick Stocks in This Economic Environment
How to Pick Stocks in This Economic...
How To Grow Your Small Business
How To Grow Your Small Business     
Private Wealth Revives, Managers Face Higher Costs
Private Wealth Revives, Managers Fa...
Private Island on the Thames: $11.7 Million
Private Island on the Thames: $11.7...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
S $ 7 0.32  4.37%
PFE $ 29.10 0.30  1.02%
BAC $ 13.19 0.08  0.60%
MU $ 13.97 0.22  1.60%
SIRI $ 3.37 0.03  0.88%
GE $ 23.98 0.35  1.44%
QQQ $ 72.76 0.82  1.11%
ELN $ 14.15 0.37  2.69%